Trait centric view

1. Trait name:	Udder depth
   Ontology terms:	VT:1000703

   231 genes are associated with this trait, with QTL/association found

   • ABCA5: ATP binding cassette subfamily A member 5
     evidenced by: QTL:158422;
   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:214783; QTL:214867; QTL:41438;
   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45075;
   • ACTE1: Actin epsilon 1
     evidenced by: QTL:54009;
   • ADAMTS16: ADAM metallopeptidase with thrombospondin type 1 motif 16
     evidenced by: QTL:50957;
   • ADAMTS17: ADAM metallopeptidase with thrombospondin type 1 motif 17
     evidenced by: QTL:50983;
   • ADAMTS6: ADAM metallopeptidase with thrombospondin type 1 motif 6
     evidenced by: QTL:50609;
   • ADGRB3: Adhesion G protein-coupled receptor B3
     evidenced by: QTL:314327;
   • AKAP6: A-kinase anchoring protein 6
     evidenced by: QTL:51224; QTL:51230;
   • ALMS1: ALMS1 centrosome and basal body associated protein
     evidenced by: QTL:45136;
   • AMOT: Angiomotin
     evidenced by: QTL:54710;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50023;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42329;
   • ANKRD31: Ankyrin repeat domain 31
     evidenced by: QTL:135445; QTL:135446;
   • AP3B1: Adaptor-related protein complex 3, beta 1 subunit
     evidenced by: QTL:44340;
   • ARHGAP10: Rho GTPase activating protein 10
     evidenced by: QTL:48704;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43073;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55470;
   • ARPIN: Actin related protein 2/3 complex inhibitor
     evidenced by: QTL:51125;
   • ATP1A3: ATPase Na+/K+ transporting subunit alpha 3
     evidenced by: QTL:49743;
   • BAZ2B: Bromodomain adjacent to zinc finger domain 2B
     evidenced by: QTL:39391;
   • BDP1: B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
     evidenced by: QTL:50536;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:51984;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41145; QTL:41156;
   • BTD: Biotinidase
     evidenced by: QTL:38995;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49676;
   • C3H1ORF87: Chromosome 3 C1orf87 homolog
     evidenced by: QTL:40024;
   • CACNA2D3: Calcium voltage-gated channel auxiliary subunit alpha2delta 3
     evidenced by: QTL:51813;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40617; QTL:40635;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44599;
   • CC2D1A: Coiled-coil and C2 domain containing 1A
     evidenced by: QTL:42732;
   • CCDC141: Coiled-coil domain containing 141
     evidenced by: QTL:39056;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41343;
   • CCL2: Chemokine (C-C motif) ligand 2
     evidenced by: QTL:9938;
   • CCR2: Chemokine (C-C motif) receptor 2
     evidenced by: QTL:9941;
   • CDH6: Cadherin 6
     evidenced by: QTL:50308;
   • CEP70: Centrosomal protein 70
     evidenced by: QTL:38835;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39117;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:52837;
   • CFAP61: Cilia and flagella associated protein 61
     evidenced by: QTL:158419;
   • CHN2: Chimerin 2
     evidenced by: QTL:40461;
   • CLDN1: Claudin 1
     evidenced by: QTL:38487;
   • CLEC16A: C-type lectin domain containing 16A
     evidenced by: QTL:52497;
   • CNKSR3: CNKSR family member 3
     evidenced by: QTL:44286;
   • CNTN5: Contactin 5
     evidenced by: QTL:47796;
   • COL12A1: Collagen type XII alpha 1 chain
     evidenced by: QTL:51970;
   • COL4A1: Collagen type IV alpha 1 chain
     evidenced by: QTL:46575;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54605;
   • CPAMD8: C3 and PZP like alpha-2-macroglobulin domain containing 8
     evidenced by: QTL:42684;
   • CPEB3: Cytoplasmic polyadenylation element binding protein 3
     evidenced by: QTL:52678;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:47693;
   • CRTC1: CREB regulated transcription coactivator 1
     evidenced by: QTL:42651;
   • CTNND1: Catenin delta 1
     evidenced by: QTL:158420;
   • CUL2: Cullin 2
     evidenced by: QTL:46822;
   • DAB1: DAB adaptor protein 1
     evidenced by: QTL:40065;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46340;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53105;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53125;
   • DOT1L: DOT1 like histone lysine methyltransferase
     evidenced by: QTL:42862;
   • DYSF: Dysferlin
     evidenced by: QTL:45165;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41935;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44108;
   • EPHB1: EPH receptor B1
     evidenced by: QTL:38846; QTL:38858; QTL:38868;
   • ESR1: Estrogen receptor 1
     evidenced by: QTL:44280;
   • ESRRG: Estrogen related receptor gamma
     evidenced by: QTL:48177;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49450;
   • FAS: Fas (TNF receptor superfamily, member 6)
     evidenced by: QTL:52662;
   • FAT3: FAT atypical cadherin 3
     evidenced by: QTL:53882; QTL:53897;
   • FBF1: Fas binding factor 1
     evidenced by: QTL:50137;
   • FBLN1: Fibulin 1
     evidenced by: QTL:41716;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51405;
   • FBRSL1: Fibrosin like 1
     evidenced by: QTL:158427;
   • FCHO1: FCH and mu domain containing endocytic adaptor 1
     evidenced by: QTL:42675;
   • FER1L5: Fer-1 like family member 5
     evidenced by: QTL:45094;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51703; QTL:51716;
   • FLT4: Fms related receptor tyrosine kinase 4
     evidenced by: QTL:42632;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51357; QTL:51370;
   • GABRR3: Gamma-aminobutyric acid type A receptor rho3 subunit
     evidenced by: QTL:38373;
   • GALNT2: Polypeptide N-acetylgalactosaminyltransferase 2
     evidenced by: QTL:53655;
   • GANC: Glucosidase alpha, neutral C
     evidenced by: QTL:44585;
   • GARS1: Glycyl-tRNA synthetase 1
     evidenced by: QTL:40448;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:214789; QTL:214870; QTL:214872; QTL:314325; QTL:95581;
   • GCLC: Glutamate-cysteine ligase catalytic subunit
     evidenced by: QTL:314328;
   • GOLT1A: Golgi transport 1A
     evidenced by: QTL:48065;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55451;
   • GPR180: G protein-coupled receptor 180
     evidenced by: QTL:158418;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54181;
   • GRIK2: Glutamate ionotropic receptor kainate type subunit 2
     evidenced by: QTL:44008;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49697;
   • GSTO2: Glutathione S-transferase omega 2
     evidenced by: QTL:52853;
   • HCRTR2: Hypocretin receptor 2
     evidenced by: QTL:51992;
   • HOXD1: Homeobox D1
     evidenced by: QTL:158416;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45987;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:47984;
   • HSD17B14: Hydroxysteroid 17-beta dehydrogenase 14
     evidenced by: QTL:49862;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54545;
   • IL8: Interleukin 8
     evidenced by: QTL:9940;
   • IL8R: Interleukin 8 receptor
     evidenced by: QTL:9944;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51438;
   • JAK1: Janus kinase 1
     evidenced by: QTL:39933; QTL:39954;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50367;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41979;
   • KCNQ1: Potassium voltage-gated channel subfamily Q member 1
     evidenced by: QTL:214806; QTL:214888;
   • KCTD2: Potassium channel tetramerization domain containing 2
     evidenced by: QTL:50161;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42570;
   • LGALS2: Galectin 2
     evidenced by: QTL:314324;
   • LIN7A: Lin-7 homolog A, crumbs cell polarity complex component
     evidenced by: QTL:40750; QTL:40767;
   • LMO7: LIM domain 7
     evidenced by: QTL:46428;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:42215;
   • LRBA: LPS responsive beige-like anchor protein
     evidenced by: QTL:48669; QTL:48680; QTL:48691;
   • LRFN2: Leucine rich repeat and fibronectin type III domain containing 2
     evidenced by: QTL:52053; QTL:52060;
   • MAGI1: Membrane associated guanylate kinase, WW and PDZ domain containing 1
     evidenced by: QTL:51658;
   • MAPKBP1: Mitogen-activated protein kinase binding protein 1
     evidenced by: QTL:44556;
   • MCUB: Mitochondrial calcium uniporter dominant negative subunit beta
     evidenced by: QTL:41950;
   • METTL15: Methyltransferase like 15
     evidenced by: QTL:47949;
   • MGAT4C: MGAT4 family member C
     evidenced by: QTL:40805;
   • MGMT: O-6-methylguanine-DNA methyltransferase
     evidenced by: QTL:53267;
   • MID1: Midline 1
     evidenced by: QTL:55503;
   • MLXIP: MLX interacting protein
     evidenced by: QTL:49350;
   • MRC2: Mannose receptor C type 2
     evidenced by: QTL:49991;
   • MSN: Moesin
     evidenced by: QTL:54833;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40997;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:38387; QTL:45754;
   • NELFA: Negative elongation factor complex member A
     evidenced by: QTL:42605;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41688;
   • NFIX: Nuclear factor I X
     evidenced by: QTL:42762; QTL:42775;
   • NHS: NHS actin remodeling regulator
     evidenced by: QTL:55250;
   • NIN: Ninein
     evidenced by: QTL:44719;
   • NMUR1: Neuromedin U receptor 1
     evidenced by: QTL:39634;
   • NOD2: Nucleotide-binding oligomerization domain containing 2
     evidenced by: QTL:9991;
   • NOX4: NADPH oxidase 4
     evidenced by: QTL:53920;
   • NPSR1: Neuropeptide S receptor 1
     evidenced by: QTL:40408;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53799; QTL:53816;
   • NRP1: Neuropilin 1
     evidenced by: QTL:46897;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42588;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41067;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44091;
   • NYAP2: Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
     evidenced by: QTL:39569;
   • OAZ1: Ornithine decarboxylase antizyme 1
     evidenced by: QTL:42846;
   • OSBPL10: Oxysterol binding protein like 10
     evidenced by: QTL:51570;
   • OSR1: Odd-skipped related transcription factor 1
     evidenced by: QTL:45636;
   • OTOP3: Otopetrin 3
     evidenced by: QTL:50175;
   • PACSIN1: Protein kinase C and casein kinase substrate in neurons 1
     evidenced by: QTL:52003;
   • PAFAH1B1: Platelet activating factor acetylhydrolase 1b regulatory subunit 1
     evidenced by: QTL:158428;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:41027;
   • PARD3: Par-3 family cell polarity regulator
     evidenced by: QTL:46836; QTL:46853; QTL:46868; QTL:46884;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53790;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50705; QTL:50725;
   • PER2: Period circadian regulator 2
     evidenced by: QTL:40315;
   • PHEX: Phosphate regulating endopeptidase homolog X-linked
     evidenced by: QTL:55163; QTL:55177;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55229; QTL:55237;
   • PLAG1: Pleiomorphic adenoma gene 1
     evidenced by: QTL:95592;
   • PLCD3: Phospholipase C delta 3
     evidenced by: QTL:50063;
   • PLCH1: Phospholipase C eta 1
     evidenced by: QTL:38695;
   • PLCH2: Phospholipase C eta 2
     evidenced by: QTL:158426;
   • PMP22: Peripheral myelin protein 22
     evidenced by: QTL:49980;
   • POLB: Polymerase (DNA directed), beta
     evidenced by: QTL:4650;
   • PRDM16: PR domain containing 16
     evidenced by: QTL:48317; QTL:48328; QTL:48343;
   • PRIM2: DNA primase subunit 2
     evidenced by: QTL:51911;
   • PRKD1: Protein kinase D1
     evidenced by: QTL:51191; QTL:51205; QTL:51218;
   • PRLHR: Prolactin releasing hormone receptor
     evidenced by: QTL:52922;
   • PTPN20: Protein tyrosine phosphatase, non-receptor type 20
     evidenced by: QTL:158431;
   • RAB15: RAB15, member RAS oncogene family
     evidenced by: QTL:44936;
   • RASA3: RAS p21 protein activator 3
     evidenced by: QTL:46587;
   • RBMS1: RNA binding motif single stranded interacting protein 1
     evidenced by: QTL:39382;
   • RCAN2: Regulator of calcineurin 2
     evidenced by: QTL:52138;
   • REN: Renin
     evidenced by: QTL:48051;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41111;
   • RMND5B: Required for meiotic nuclear division 5 homolog B
     evidenced by: QTL:42997;
   • RNF157: Ring finger protein 157
     evidenced by: QTL:50097;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45913;
   • ROR1: Receptor tyrosine kinase like orphan receptor 1
     evidenced by: QTL:39982;
   • RPAP1: RNA polymerase II associated protein 1
     evidenced by: QTL:44545;
   • RPS6KC1: Ribosomal protein S6 kinase C1
     evidenced by: QTL:48473;
   • RSPO2: R-spondin 2
     evidenced by: QTL:47660;
   • RUNX1: RUNX family transcription factor 1
     evidenced by: QTL:38966;
   • SEC23IP: SEC23 interacting protein
     evidenced by: QTL:53019;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41864;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43979;
   • SERINC3: Serine incorporator 3
     evidenced by: QTL:47364;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52470;
   • SFXN1: Sideroflexin 1
     evidenced by: QTL:135443;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52989;
   • SGTA: Small glutamine rich tetratricopeptide repeat co-chaperone alpha
     evidenced by: QTL:42824;
   • SH2D2A: SH2 domain containing 2A
     evidenced by: QTL:39756;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55644; QTL:55652;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48722;
   • SLC24A4: Solute carrier family 24 member 4
     evidenced by: QTL:51415;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39091;
   • SLC39A10: Solute carrier family 39 member 10
     evidenced by: QTL:39485;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:41460;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50330; QTL:50347;
   • SMARCA5: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
     evidenced by: QTL:48840;
   • SNX29: Sorting nexin 29
     evidenced by: QTL:52518;
   • SOAT1: Sterol O-acyltransferase 1
     evidenced by: QTL:158421;
   • SORT1: Sortilin 1
     evidenced by: QTL:158417;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:42354; QTL:42370;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39616;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43023; QTL:43040;
   • SRGAP2: SLIT-ROBO Rho GTPase activating protein 2
     evidenced by: QTL:48111;
   • SRP68: Signal recognition particle 68
     evidenced by: QTL:50112;
   • SUN2: Sad1 and UNC84 domain containing 2
     evidenced by: QTL:41585;
   • SYN3: Synapsin III
     evidenced by: QTL:41193; QTL:41215; QTL:41234;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39353;
   • TASP1: Taspase 1
     evidenced by: QTL:46772;
   • TBC1D12: TBC1 domain family member 12
     evidenced by: QTL:52694;
   • TEN1: TEN1 subunit of CST complex
     evidenced by: QTL:50127;
   • TGM7: Transglutaminase 7
     evidenced by: QTL:51308;
   • TIMP2: TIMP metallopeptidase inhibitor 2
     evidenced by: QTL:50080;
   • TM9SF2: Transmembrane 9 superfamily member 2
     evidenced by: QTL:46531;
   • TMEM87B: Transmembrane protein 87B
     evidenced by: QTL:45057;
   • TPCN1: Two pore segment channel 1
     evidenced by: QTL:49398;
   • TRIM23: Tripartite motif containing 23
     evidenced by: QTL:50593;
   • TTI1: TELO2 interacting protein 1
     evidenced by: QTL:158425;
   • TTYH2: Tweety family member 2
     evidenced by: QTL:50204;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53622;
   • UBR1: Ubiquitin protein ligase E3 component n-recognin 1
     evidenced by: QTL:44629; QTL:44643;
   • UGT2A1: UDP glucuronosyltransferase family 2 member A1 complex locus
     evidenced by: QTL:42226;
   • UNC5D: Unc-5 netrin receptor D
     evidenced by: QTL:53521;
   • WDFY3: WD repeat and FYVE domain containing 3
     evidenced by: QTL:42475; QTL:42490;
   • WDR41: WD repeat domain 41
     evidenced by: QTL:135449;
   • WWC3: WWC family member 3
     evidenced by: QTL:55588; QTL:55606;
   • XPO5: Exportin 5
     evidenced by: QTL:52106;
   • XRCC4: X-ray repair cross complementing 4
     evidenced by: QTL:43336;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40978;
   • ZNF280C: Zinc finger protein 280C
     evidenced by: QTL:54305;
   • ZNF280D: Zinc finger protein 280D
     evidenced by: QTL:44789;
   • ZNF404: Zinc finger protein 404
     evidenced by: QTL:49789;
   • ZNF521: Zinc finger protein 521
     evidenced by: QTL:158424;
   • ZNF592: Zinc finger protein 592
     evidenced by: QTL:51149;
   • ZNF891: Zinc finger protein 891
     evidenced by: QTL:49237;
   428 correlations are found involving Udder depth